OTCMKTS:CYAN Cyanotech (CYAN) Stock Price, News & Analysis $0.49 -0.04 (-7.53%) As of 07/13/2026 12:38 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartEarningsInsider TradesSEC FilingsBuy This Stock About Cyanotech Stock (OTCMKTS:CYAN) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Cyanotech alerts:Sign Up Key Stats Today's Range$0.49▼$0.5350-Day Range$0.37▼$0.5552-Week Range$0.21▼$0.57Volume3,828 shsAverage Volume1,198 shsMarket Capitalization$3.62 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Cyanotech Corp. engages in the cultivation, production, and sale of natural products derived from microalgae for the health and human nutrition markets worldwide. Its products include BioAstin Hawaiian Astaxanthin, a dietary antioxidant, which is used as a human dietary supplement and dietary ingredient to support and maintain the body's natural inflammatory response, enhance skin, and support eye, joint, and immune health; and Hawaiian Spirulina Pacifica, a nutrient-rich dietary supplement that is used for extra energy, a strengthened immune system, cardiovascular benefits, and as a source of antioxidant carotenoids. The company was founded by Gerald R. Cysewski in 1983 and is headquartered in Kailua-Kona, HI. Read More Cyanotech Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks7th Percentile Overall ScoreCYAN MarketRank™: Cyanotech scored higher than 7% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for Cyanotech. Earnings and Valuation0.6 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Cyanotech is -1.96, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Cyanotech is -1.96, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioCyanotech has a P/B Ratio of 0.47. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.00% of the float of Cyanotech has been sold short.Short Interest Ratio / Days to CoverCyanotech has a short interest ratio ("days to cover") of 0.05, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Cyanotech has recently increased by 2.70%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldCyanotech does not currently pay a dividend.Dividend GrowthCyanotech does not have a long track record of dividend growth. News and Social Media0.6 / 5News SentimentN/A MarketBeat Follows1 people have added Cyanotech to their MarketBeat watchlist in the last 30 days. Company Ownership1.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Cyanotech insiders have not sold or bought any company stock.Percentage Held by Insiders34.40% of the stock of Cyanotech is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions24.40% of the stock of Cyanotech is held by institutions.Read more about Cyanotech's insider trading history. Receive CYAN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cyanotech and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CYAN Stock News HeadlinesCyanotech Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2024May 20, 2026 | finanznachrichten.deSpirulina Extract Market | 6.0% CAGR | Asia Pacific, USA, Europe Lead | DIC Corp, Cyanotech, Parry Nutraceuticals Drive Clean-Label RevolutionApril 8, 2026 | finance.yahoo.comFrom the man who predicted 2008 crash…Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the biggest story of his 26-year career - an economic shift not seen since 1776. From the government taking stakes in Intel, Lithium Americas, and MP Materials, to sweeping political changes reshaping the economy, Stansberry argues a rare 'New 1776 Moment' is already underway. One Nobel Prize winner calls it a dividing line for all of society. His presentation covers the stocks to buy, the stocks to sell, and three money moves to position yourself on the right side of this shift. | Porter & Company (Ad)Cyanotech Corp.February 13, 2026 | marketwatch.comCyanotech Corp (CYAN) Q2 2026 Earnings Call Highlights: Revenue Surge and Margin Expansion ...November 19, 2025 | finance.yahoo.comCyanotech Corporation (CYAN) Q2 2026 Earnings Call Prepared Remarks TranscriptNovember 11, 2025 | seekingalpha.comCyanotech Reports Financial Results for the Second Quarter of Fiscal 2026November 10, 2025 | businesswire.comCyanotech Stock Price History - Investing.comAugust 24, 2025 | investing.comSee More Headlines CYAN Stock Analysis - Frequently Asked Questions How have CYAN shares performed this year? Cyanotech's stock was trading at $0.45 on January 1st, 2026. Since then, CYAN shares have increased by 8.9% and is now trading at $0.49. How were Cyanotech's earnings last quarter? Cyanotech Co. (OTCMKTS:CYAN) issued its quarterly earnings data on Monday, June, 29th. The biotechnology company reported $0.00 earnings per share (EPS) for the quarter. Cyanotech had a negative net margin of 4.82% and a negative trailing twelve-month return on equity of 16.24%. How do I buy shares of Cyanotech? Shares of CYAN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Cyanotech own? Based on aggregate information from My MarketBeat watchlists, some other companies that Cyanotech investors own include AbbVie (ABBV), Gilead Sciences (GILD), Pfizer (PFE), Karyopharm Therapeutics (KPTI) and Madrigal Pharmaceuticals (MDGL). Company Calendar Last Earnings6/29/2026Today7/13/2026Fiscal Year End3/31/2027Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medicinals & botanicals Sub-IndustryN/A Current SymbolOTCMKTS:CYAN CIK768408 Webwww.cyanotech.com Phone(808) 326-1353Fax808-329-4533Employees95Year FoundedN/AProfitability EPS (Trailing Twelve Months)($0.25) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$1.28 million Net Margins-4.82% Pretax Margin-4.80% Return on Equity-16.24% Return on Assets-5.56% Debt Debt-to-Equity Ratio0.13 Current Ratio1.02 Quick Ratio0.42 Sales & Book Value Annual Sales$26.59 million Price / Sales0.14 Cash Flow$0.08 per share Price / Cash Flow6.38 Book Value$1.04 per share Price / Book0.47Miscellaneous Outstanding Shares7,390,000Free Float4,849,000Market Cap$3.62 million OptionableNot Optionable Beta0.12 Options Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free Report This page (OTCMKTS:CYAN) was last updated on 7/14/2026 by MarketBeat.com Staff. From Our PartnersSPCX Warning - and Worst News for Stocks in 50 YearsGoldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...TradeSmith | SponsoredTrump’s $250 Bill – See ImmediatelyFormer Goldman Sachs VP Dr. David Eifrig is warning that July 28 could trigger the biggest wealth reset in mod...Stansberry Research | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredThey told you not to miss this oneThe largest companies in the SP 500 are now more overvalued relative to fundamentals than they were at the abs...Thor Metals | SponsoredForget SpaceX, this is Elon’s Next BreakthroughJeff Brown and Marc Chaikin - two investors who called Nvidia a decade ago - say Elon Musk's newly filed AI pa...Brownstone Research | SponsoredWhen I found Rolls-Royce under $2, most people thought I was crazyIn 2022, Karim Rahemtulla recommended Rolls-Royce when it traded under $2. The stock climbed more than 1,100% ...Monument Traders Alliance | SponsoredBuy this stock todayMarc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...Chaikin Analytics | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cyanotech Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cyanotech With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
